## Abstract The aim of the present study was to elucidate the tumorβspecific cellular immunological responses occurring in a patient with large cell carcinoma of the lung who had no evidence of recurrence following surgical resections of both a primary lung lesion and a metastatic adrenal lesion. W
Identification of a mutated tumor-specific peptide recognized by HLA-B52-restricted cytotoxic T lymphocytes on a squamous cell carcinoma of the lung
β Scribed by Sugaya, M; Takenoyama, M; Yasuda, M; So, T; Eifuku, R; Yoshimatsu, T; Oyama, T; Coulie, P; Boon, T; Yasumoto, K
- Book ID
- 118570134
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 199 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have described the SART-1 gene-encoding peptides recognized by HLA-A2601-restricted and tumor-specific cytotoxic T lymphocytes (CTLs). We now have investigated whether SART-1 encodes peptides capable of inducing the HLA-A24-restricted CTLs. Among the 18 different peptides with HLA-A24-binding mot
Previous studies have shown that self-antigens overexpressed in malignant tissue can provide a basis for a tumorspecific immune response. The mucin MUC2 is strongly overexpressed in all mucinous tumors of colon, breast, ovary and pancreas. In the corresponding normal tissue it is either not expresse
## Abstract We have identified an antigen recognized by cytolytic T lymphocytes (CTL) on the autologous tumor cells of a nonsmall cell lung cancer patient. The antigenic peptide, presented by HLAβB\*5201 molecules, was encoded by a mutated sequence in the gene coding for the C subunit of transcript
The human melanocyte lineage-specific antigen gp100 contains several epitopes recognized by cytotoxic T lymphocytes (CTL). However, most of the epitopes reported to date are HLA-A2.1-restricted. Despite the high frequency of HLA-A2.1 in melanoma patients, effective population coverage requires the i